Caffeine acts as an adenosine receptor antagonist, blocking A1 and A2A receptors and potentially modulating neuronal excitability in Visual Snow Syndrome. By inhibiting adenosine's inhibitory effects, caffeine can increase neuronal activity and neurotransmitter release, which may help mitigate some neurological symptoms associated with the syndrome. However, its efficacy is still under investigation, and individual responses can vary significantly.